IL18 and systemic-onset juvenile idiopathic arthritis: In support of this, SJIA is characterized by increased circulating innate immune effectors, upregulation of monocyte/macrophage differentiation genes, as well as high levels of monocyte-derived proinflammatory cytokines including IL-1, IL-6, and IL-18 (5–12).